Why Automation Reduces Risk and Reinforces Clinical Data Quality

Clinical Researcher

The people collecting and handling clinical data report that the tools and processes currently used in clinical trials are slowing them down. In fact, new industry research shows it might be interfering with the quality of data. Two-thirds of data managers and clinical research associates think data quality in clinical trials is at risk if the inefficiencies in execution persist. This highlights a known challenge in the industry—there are too many manual steps and disconnected technologies that don’t work together to conduct tasks.

We Have the Tools We Need

Clinical Researcher

As ACRP gets ready to celebrate its 50th Anniversary in 2026, we are ready to help ensure that our members are prepared for what's next in clinical research. We are shaping your expertise into an education-packed conference and ensuring that our training is accurate, relevant, and career-building. We have the tools we need as we continue to do our important work to support you. I know that you, the members of our amazing ACRP clinical research community, will continue, in turn, to support each other.

Artificial Intelligence is Reaching into Every Corner of the Clinical Trial Lifecycle

Blog

With seemingly unavoidable and unceasing headlines such as “FDA Rolls Out Agentic AI for Staffers,” “How AI is Transforming Clinical Trials,” and “New AI System Could Accelerate Clinical Research” hitting the news feeds every day, it’s no wonder some observers from the trenches of the drug and device development industry want to separate the honest hope from the breathless hype when it comes to how artificial intelligence (AI) is being applied to their everyday working lives. 

Introducing Participants to Clinical Trials Via Non-Drug Studies

Blog

Taking an experimental drug is likely the first thing that comes to mind for most people who’ve never participated in human subjects research when the prospect of joining a clinical trial comes up. However, speakers who are getting ready to present a session at the ACRP 2026 conference in Orlando next April say that it’s important for research centers in any community—especially highly diverse and minority-rich communities—to consider offering other types of studies to the populations they serve to help foster trust in clinical trials.